514-65-8
514-65-8 structure
- Name: biperiden
- Chemical Name: biperiden
- CAS Number: 514-65-8
- Molecular Formula: C21H29NO
- Molecular Weight: 311.461
- Catalog: API Nervous system medication Anti-shock palsy
- Create Date: 2018-05-13 08:00:00
- Modify Date: 2026-06-30 18:19:53
-
Biperiden(KL 373) is an antiparkinsonian agent, which is the selective central M1 cholinoreceptors blocker.Target: M1 receptorsBiperiden is an antiparkinsonian agent of the anticholinergic type. It is used for the adjunctive treatment of all forms of Parkinson's disease (postencephalitic, idiopathic, and arteriosclerotic)[1]. Biperiden has an atropine-like blocking effect on all peripheral structures which are parasympathetic-innervate. It also has a prominent central blocking effect on M1 receptors [2].Biperiden (0.11 mg/kg), benactyzine (0.3 mg/kg),caramiphen (10 mg/kg), procyclidine (3 mg/kg), and trihexyphenidyl (0.12 mg/kg) separately and each in combination with physostigmine (0.1 mg/kg) is to make a comparative assessment of potential cognitive effects. The results showed that benactyzine, caramiphen, and trihexyphenidyl reduced rats' innate preference for novelty, whereas biperiden and procyclidine did not [3].Clinical indications: parkinsonismFDA Approved Date: Toxicity: Drowsiness; vertigo; headache; dizziness
| Name | biperiden |
|---|---|
| Synonyms |
α-(Bicyclo[2.2.1]ht-5-en-2-yl)-α-phenyl-1-piperidine-1-propanol
1-Bicyclohtenyl-1-phenyl-3-piperidino-propanol-1 Bipiden Impurity 3-Piperidino-1-phenyl-1-bicyclo(2.2.1)hten-yl-propanol Bibristan alpha-(bicyclo(2.2.1)ht-5-en-2-yl)-alpha-phenyl-1-piperidinopropanol EINECS 208-184-6 Biperideno 5-Norbornene-2-methanol, alpha-phenyl-alpha-(2-piperidinoethyl) Alpha-5-Norbornene-2-yl-alphaphentl-1-piperidinropanol (Biperiden base) 1-norborn-5-en-2-yl-1-phenyl-3-piperidino-propan-1-ol 1-Piperidinropanol, alpha-bicyclo[2.2.1]ht-5-en-2-yl-alpha-phenyl Biperidene 1-Piperidinropanol, a-5-norbornen-2-yl-a-phenyl- (6CI, 7CI, 8CI) Biperiden Hcl -/ /IP/JP Biperidine Akinophyl Bipiden //BP bipiden alpha-phenyl-alpha-(2-piperidinoethyl)-5-norbornene-2-methano 1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol 1-Bicycloheptenyl-1-phenyl-3-piperidinopropanol 3-Piperidino-1-phenyl-1-bicyclo Biperidenum alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinropanol Biperideno [INN-Spanish] alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinropano 1-[(1R,4R)-Bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(1-piperidinyl)-1-propanol 1-(Bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(1-piperidinyl)-1-propanol 3-Piperidino-1-phenyl-1-bicyclohtenyl-1-propanol BiperidenHcl Biperidene [INN-French] 1-Piperidinropanol, α-bicyclo[2.2.1]ht-5-en-2-yl-α-phenyl Biperiden (Mixture of diastereomers) 1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-(1-piperidyl)propan-1-ol Bicyclo[2,2,1]ht-5-en-2yl-phenyl-1-piperidinropanol a-bicyclo[2.2.1]ht-5-en-2yl-a-phenyl-1-piperidinropanol α-(Bicyclo[2.2.1]ht-5-en-2-yl)-α-phenyl-1-piperidinopropanol Biperiden 1-phenyl-3-piperidino-1-(8,9,10-trinorborn-5-en-2-yl)propan-1-ol Beperiden alpha-(Bicyclo(2.2.1)ht-5-en-2-yl)-alpha-phenyl-1-piperidino propanol kl373 Beriden alpha-bicyclo(2.2.1)ht-5-en-2-yl-alpha-phenyl-1-piperidinropano 1-(Bicyclo[2.2.1]ht-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol a-5-Norbornen-2-yl-a-phenyl-1-piperidinepropanol 5-Norbornen-2-yl-phenyl-1-piperidinropanol 1-Bicyclo[2.2.1]ht-5-en-2-yl-1-phenyl-3-(1-piperidinyl)-1-propanol UNII:0FRP6G56LD 1-(Bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol 1-norborn-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol 3-Piperidino-1-phenyl-(D5-bicyclo[2.2.1]hepten-2-yl)-1-propanol Biperiden Hydrochloride Akineton 1-Piperidinropanol, a-bicyclo[2.2.1]ht-5-en-2-yl-a-phenyl 1-(5-bicyclo[2.2.1]ht-2-enyl)-1-phenyl-3-(1-piperidyl)propan-1-ol Bicyclo[2.2.1]ht-5-ene-2-methanol, alpha-phenyl-alpha-[2-(1-piperidinyl)ethyl] a-Bicyclo[2.2.1]hept-5-en-2-yl-a-phenyl-1-piperidinepropanol Biperidenum [INN-Latin] 1-Piperidinropanol, alpha-5-norbornen-2-yl-alpha-phenyl |
| Description | Biperiden(KL 373) is an antiparkinsonian agent, which is the selective central M1 cholinoreceptors blocker.Target: M1 receptorsBiperiden is an antiparkinsonian agent of the anticholinergic type. It is used for the adjunctive treatment of all forms of Parkinson's disease (postencephalitic, idiopathic, and arteriosclerotic)[1]. Biperiden has an atropine-like blocking effect on all peripheral structures which are parasympathetic-innervate. It also has a prominent central blocking effect on M1 receptors [2].Biperiden (0.11 mg/kg), benactyzine (0.3 mg/kg),caramiphen (10 mg/kg), procyclidine (3 mg/kg), and trihexyphenidyl (0.12 mg/kg) separately and each in combination with physostigmine (0.1 mg/kg) is to make a comparative assessment of potential cognitive effects. The results showed that benactyzine, caramiphen, and trihexyphenidyl reduced rats' innate preference for novelty, whereas biperiden and procyclidine did not [3].Clinical indications: parkinsonismFDA Approved Date: Toxicity: Drowsiness; vertigo; headache; dizziness |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 462.1±40.0 °C at 760 mmHg |
| Melting Point | 114ºC |
| Molecular Formula | C21H29NO |
| Molecular Weight | 311.461 |
| Flash Point | 224.5±26.0 °C |
| Exact Mass | 311.224915 |
| PSA | 23.47000 |
| LogP | 4.01 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.583 |
| Water Solubility | 25.1 mg/L |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| RIDADR | NONH for all modes of transport |
|---|---|
| HS Code | 2933399090 |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |